Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Rinsho Ketsueki ; 64(11): 1397-1403, 2023.
Article in Japanese | MEDLINE | ID: mdl-38072424

ABSTRACT

The IFM/DFCI group reported that VRD induction followed by up-front autologous peripheral blood stem cell transplantation (ASCT) and maintenance therapy led to median PFS of 50 months, which established up-front ASCT as the standard of care even in the era of novel agents. We conducted a retrospective analysis on outcomes of patients who received triplet induction therapy followed by up-front ASCT at our institution. A total of 124 patients received ASCT between November 2016 and December 2021 at Japanese Red Cross Medical Center. Patient characteristics, treatment response before and after ASCT, and PFS and OS were retrospectively analyzed. VRD-based induction therapy was used for 94%. Among 118 evaluable patients, 116 (98%) received either consolidation and/or maintenance therapy. Best responses were ≥CR 77% and ≥VGPR 94%, respectively. Sixty-eight out of 104 patients achieved MRD-negativity by multiparameter FCM (<10-5). Five-year estimated PFS and OS were 54.7% and 80.2%, respectively. Age ≥65, high-risk cytogenetic abnormalities, and

Subject(s)
Hematopoietic Stem Cell Transplantation , Multiple Myeloma , Humans , Antineoplastic Combined Chemotherapy Protocols , Bortezomib/therapeutic use , Induction Chemotherapy , Multiple Myeloma/drug therapy , Prospective Studies , Retrospective Studies , Transplantation, Autologous , Treatment Outcome , Aged
2.
Rinsho Ketsueki ; 64(8): 731-734, 2023.
Article in Japanese | MEDLINE | ID: mdl-37673623

ABSTRACT

A 28-year-old female was diagnosed with acute myeloid leukemia (AML) due to t (8;21) (q22;q22.1); RUNX1-RUNX1T1 at 21 weeks of gestation. Because no adverse prognostic genetic mutations were discovered, we decided to continue the pregnancy without chemotherapy for as long as possible. After careful monitoring with blood tests every two weeks, the disease did not progress until full-term, and a cesarean section was performed at 39 weeks of gestation. About two months after delivery, blasts in the peripheral blood increased to 46.5%, and myeloblasts in the bone marrow increased to 21.2%. The patient received idarubicin and cytarabine induction therapy, followed by three cycles of high-dose cytarabine consolidation therapy, and complete remission was maintained. Here we report a rare case who could avoid chemotherapy until full-term labor without progression of AML.


Subject(s)
Cesarean Section , Leukemia, Myeloid, Acute , Pregnancy , Humans , Female , Adult , Leukemia, Myeloid, Acute/drug therapy , Leukemia, Myeloid, Acute/genetics , Translocation, Genetic , Idarubicin/therapeutic use , Cytarabine/therapeutic use
3.
Ann Hematol ; 102(6): 1477-1483, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37115297

ABSTRACT

Isatuximab and daratumumab are anti-CD38 monoclonal antibodies used to treat refractory multiple myeloma. Isatuximab is often used after unsuccessful daratumumab treatment; however, the clinical benefits of receiving isatuximab after daratumumab treatment have not been fully evaluated. Therefore, this retrospective cohort study assessed the clinical outcomes of 39 patients with multiple myeloma who were administered isatuximab after daratumumab. The median follow-up period was 8.7 months (range 0.1-25.0 months). The overall response rate was 46.2% (18 patients). The 1-year overall survival was 53.9%, with a median progression-free survival of 5.6 months. The median progression-free survival in patients with high and normal lactate dehydrogenase levels was 4.5 and 9.6 months, respectively (P = 0.004). The median progression-free survival in patients with and without triple-class refractory disease was 5.1 months and not reached, respectively (P = 0.001). The median overall survival in patients with high and normal lactate dehydrogenase levels was not reached and 9.3 months, respectively (P = 0.001). The median overall survival in patients with and without triple-class refractory disease was 9.9 months and not reached, respectively (P = 0.038). Our findings provide insight into the optimal use and timing of anti-CD38 antibody therapy.


Subject(s)
Multiple Myeloma , Humans , Retrospective Studies , Antibodies, Monoclonal/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Lactate Dehydrogenases , Dexamethasone
4.
J Nat Med ; 76(1): 87-93, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34357482

ABSTRACT

Cinnamon bark is an important spice worldwide. In this study, the chemical diversity of various commercially available cinnamon barks that differed in their production areas and utility applications (culinary spice or medicines) were investigated by the use of 1H NMR metabolomics. Our results indicated that principle component analysis (PCA) and hierarchical cluster analysis (HCA) of the 1H NMR spectra of the cinnamon bark methanolic extracts including the deduction of their species by nucleotide sequence analysis enabled differentiation of the cinnamon barks according to their species, production areas and utility applications. The constituents of Vietnam cinnamon were found to differ significantly from the other samples investigated based on PCA score plots and HCA constellation dendrograms. Coumarin was found to be a key compound for the discrimination of Vietnamese cinnamon by multivariate analysis of the 1H NMR spectral data and direct comparison of the 1H NMR spectra. In addition, coumarin was quantified using quantitative NMR methods. As a result, coumarin was contained in Vietnamese cinnamon at a higher level compared to other cinnamons. This study indicated that 1H NMR metabolomics could deduce spices, utility, and producing area of commercially available cinnamon barks. Furthermore, combining quantitative 1H NMR methods with 1H NMR metabolomics enable quantification of coumarin in cinnamon bark on a single measurement.


Subject(s)
Cinnamomum zeylanicum , Coumarins , Metabolomics , Principal Component Analysis , Vietnam
5.
ACS Appl Mater Interfaces ; 7(28): 15667-73, 2015 Jul 22.
Article in English | MEDLINE | ID: mdl-26115554

ABSTRACT

A versatile method for the rapid fabrication of aligned fullerene C60 nanowhiskers (C60NWs) at the air-water interface is presented. This method is based on the vortex motion of a subphase (water), which directs floating C60NWs to align on the water surface according to the direction of rotational flow. Aligned C60NWs could be transferred onto many different flat substrates, and, in this case, aligned C60NWs on glass substrates were employed as a scaffold for cell culture. Bone forming human osteoblast MG63 cells adhered well to the C60NWs, and their growth was found to be oriented with the axis of the aligned C60NWs. Cells grown on aligned C60NWs were more highly oriented with the axis of alignment than when grown on randomly oriented nanowhiskers. A study of cell proliferation on the C60NWs revealed their low toxicity, indicating their potential for use in biomedical applications.


Subject(s)
Cell Proliferation , Fullerenes/chemistry , Nanostructures/chemistry , Osteoblasts/cytology , Polymers/chemical synthesis , Tissue Engineering/instrumentation , Tissue Scaffolds/chemistry , Cell Adhesion , Cell Line , Humans , Polymers/chemistry
6.
Adv Mater ; 27(27): 4020-6, 2015 Jul 15.
Article in English | MEDLINE | ID: mdl-26033774

ABSTRACT

A highly aligned 1D fullerene whisker (FW) scaffold in a centimeter area is fabricated by interfacial alignment. The resulting aligned FW scaffold enables concurrent control over cellular orientation and differentiation to muscle cells. This aligned FW scaffold is made by a facile method, and hence the substrate is a promising alternative to other cell scaffolds for tissue engineering.


Subject(s)
Cell Adhesion/physiology , Cell Differentiation/physiology , Fullerenes , Myoblasts/physiology , Tissue Engineering/instrumentation , Tissue Scaffolds , Animals , Cell Line , Cell Survival/physiology , Fullerenes/chemistry , Immunohistochemistry , Mice , Microscopy, Atomic Force , Microscopy, Confocal , Microscopy, Electron, Scanning , Myosin Heavy Chains/metabolism , Optical Imaging , Tissue Engineering/methods , Tissue Scaffolds/chemistry , Vinculin/metabolism
7.
PLoS One ; 8(7): e68669, 2013.
Article in English | MEDLINE | ID: mdl-23874714

ABSTRACT

To find histone deacetylase 3 (HDAC3)-selective inhibitors, a series of 504 candidates was assembled using "click chemistry", by reacting nine alkynes bearing a zinc-binding group with 56 azide building blocks in the presence of Cu(I) catalyst. Screening of the 504-member triazole library against HDAC3 and other HDAC isozymes led to the identification of potent and selective HDAC3 inhibitors T247 and T326. These compounds showed potent HDAC3 inhibition with submicromolar IC50s, whereas they did not strongly inhibit other isozymes. Compounds T247 and T326 also induced a dose-dependent selective increase of NF-κB acetylation in human colon cancer HCT116 cells, indicating selective inhibition of HDAC3 in the cells. In addition, these HDAC3-selective inhibitors induced growth inhibition of cancer cells, and activated HIV gene expression in latent HIV-infected cells. These findings indicate that HDAC3-selective inhibitors are promising candidates for anticancer drugs and antiviral agents. This work also suggests the usefulness of the click chemistry approach to find isozyme-selective HDAC inhibitors.


Subject(s)
Click Chemistry/methods , Histone Deacetylase Inhibitors/chemistry , Histone Deacetylases/drug effects , Drug Evaluation, Preclinical , HCT116 Cells , Humans , Triazoles/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...